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D. Abstract 
 
Background 
Cervical cancer is the most common cancer in Nepal and most often they are diagnosed as 
stage 2 or more. Despite having country’s cancer referral hospital B.P Koirala Memorial 
Cancer Hospital (BPKMCH), the biggest well equipped in terms of infrastructure, treatment 
facility and expert manpower is in Bharatpur, organized cervical cancer screening service is 
not yet exists in this area.  
 
Objective 
To start a new programme like this it is essential to assess a cervical cancer program and its 
ability to detect a proportion of possible abnormal cervical smear and assess women’s barrier 
for attending cervical cancer screening service. Thus the present study aims at identifying 
determinants of these factors that are necessary for successful cervical cancer screening 
programme in Bharatpur, Nepal.  
 
Methods 
Population based cross sectional study was carried out from October 2006 to march 2007. 
1547 ever married women aged 15-59 were selected with cluster randomization procedure 
from ward number 11 Bharatpur municipalities. Ethical clearance to carry out this study was 
sought from Nepal Health Research council (NHRC) ethical clearance committee. Pap smear 
test was carried out in BPKMCH and reporting was done on Bethesda system. Interviews 
were performed using a standard questionnaire pertaining to socio-demographic and 
reproductive characteristics, their awareness and knowledge regarding cervical cancer and 
their barriers to utilize the cervical cancer screening service. 
 
Results 
Out of 1547 total study population 1033 participated in the study and 977of them had Pap 
smear. Proportion of abnormal cervical smear detected in this study includes ASC: 2.86%, 
LSIL: 0.2% and HSIL: 0.5%. Thus total prevalence of different grades of abnormal cervical 
smear was found to be 3.5%. Those who had previous Pap smear 29% belongs to women 
aged 16-29, 46.6% with aged 30-44 and 42% with aged 45-59.  
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Though 40% have heard of cervical cancer only 26% have responded correctly about the 
possible prevention and 24.7% responded correctly for its treatable nature when diagnosed 
early. Health workers role for information dissemination was found lower (47.8%) than mass 
media and social networks78.5% & 78.5% respectively.  
Increase proportion of women with awareness of cervical cancer is noted as education level 
increases and chances of having previous Pap smear among women who have heard of 
cervical cancer is noted twice than those who have not heard. These differences in proportion 
were significant with P value of 0.000. 
33.2% of the total study population were non participant. Among them 71% were from non 
slum area compared to 29% from slum area. Major determinants of these women’s barrier 
were their lack of perception about preventive role of Pap smear, lack of time and lack of 
permission from there husband to go to cervical cancer screening.  
 
Conclusion 
Proportion of women with HSIL in our study was not more than other study in developed 
country, yet cervical cancer is number one malignancy in Nepal. Existence of many societal 
behavioural patterns in Nepal that are risk to cervical cancer and present opportunistic 
cervical cancer screening services which  have low coverage rate of cervical cancer screening  
for women with aged 30s and 40s who are considered highest risk group makes the 
establishment of organized screening service a must. 
Favourable rate of participation from women with lower socio economic status in our study 
could be due to free cervical cancer screening service that we have provided. Therefore to 
reach women with lower socioeconomic status the screening fee must be very nominal. 
Awareness of cervical cancer is crucial factor to increase cervical cancer screening coverage. 
Dissemination of proper information to the women, their husband and community at large and 
inclusion of women’s barrier in the community to cervical cancer information is a pre-
requisite to have increase cervical cancer screening coverage.  
 
Key words:  Cervical cancer, prevalence, abnormal cervical smear, Pap smear, coverage, 
organized cervical cancer screening, awareness, knowledge, barriers, Bharatpur, Nepal. 
This study was done in collaboration with International agency for Research on Cancer 
(IARC), France and supported by grant through Gates Foundation. 
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E. Introduction 
 
Global Magnitude of the Cervical Cancer 
According to Alliance for Cervical Cancer Prevention (ACCP) 2004, cervical cancer is the 
most common form of cancer in women in virtually all developing countries  
 
and the second most common form of cancer in women in the world following breast cancer. 
(1)  It constitutes approximately 12% of all cancers in women. Globally, 500,000 new cases 
are diagnosed every year and 300,000 deaths are secondary to cervical cancer. Among these 
global estimates 80% harbors in developing countries. (2) 
 
Early detection and screening along with health education programmes have been successful 
in reducing morbidity and mortality up to 80%, in most developed countries.(2)  
 
Background of the Country 
Nepal is landlocked country bordering China in the north and India on south. Topographically 
it is divided into three distinct ecological zones (mountains, hills and Terai).Total area of the 
country is 147,181 square kilometers. Terai (plain) covers 34,019 square kilometer and is 
inhabited by 49 percent of the population. 
 
Map of Nepal 
 
 viii 
 
 
Basic Demography and Health Indicators of Nepal 
Indicator Value/Nominator 
Total population (2001) 
Annual population growth rate 
Life expectancy at birth 
Total fertility rate (2001) 
Contraceptive prevalence rate (2001) 
Maternal mortality ratio (1999)    
Age at first marriage (women) 
Adult female literacy rate (2001) 
23.5 million                    
2.27 
59.7 
4.1 
39.3 
539/100 000 
16.7 years                                    
28.7% 
 
Risk factors for Cervical Cancer 
It has been already documented that acquisition and interaction with certain subtypes of 
Human papilloma virus (HPV) such as type 16,18, 31 ,33 etc which are considered as high 
risk HPV(hr-HPV) is the central necessary cause for cervical cancer.(3) Cofactors such as high 
parity, oral contraceptive use, smoking etc are also risk factor for acquiring cervical 
cancer.(2)Thus in our setting socio-demographic indicator of the country itself is a risk factor 
for acquiring cervical cancer with early childbirth in consequence of early marriage, low 
women literacy rate, high fertility rate and  majority of the population  with poor 
socioeconomic status. (4)  
 
Magnitude of the cervical cancer in Nepal: 
According to World health organization (WHO), 2002 China and India had 131,500 and 
125,952 new cases of cervical cancer per year respectively. (5)Based on these two neighbor 
countries incidence data and based on similar socio-cultural pattern between Nepal and India, 
we can predict that Nepal must have alarming incidence rate for cervical cancer. This is 
further supported by finding in the hospital based cancer registry in B.P.Koirala Memorial 
Cancer Hospital (BPKMCH). Cervical cancer is the most frequently detected malignancy in 
Nepal.(6) Population based cancer registry is not available in Nepal and also prevalence and 
incidence of cancer at population level is not yet known. A population based study including 
5000 women aged 30-59, carried out in 2003 in collaboration between BPKMCH and 
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International Agency for Research on Cancer (IARC) found 2.5% prevalence for 
precancerous lesion and 0.12 % for invasive cancer.  
 
Health Facility Pertaining to Cervical Cancer at Study Area 
BPKMCH, the biggest cancer referral hospital (100 beds, established in 1996) is located in 
Bharatpur, Chitawan, in Terai region, 150 km south west from the capital (Kathmandu). The 
hospital consist of  all units relevant to cervical cancer including gynecology oncology unit, 
radiation oncology unit, anesthesia, pathology, radio diagnosis and imaging and cancer 
prevention, control and research and  palliative therapy. 
Examinations to Papanicolaou smear (Pap smear), Colposcopy, Cervical Biopsy, Endometrial 
Biopsy, Endocervical Curettage, Cryotherapy and Loop Electro Excision Procedure (LEEP) 
were routinely performed in gynecology unit and the services are provided by gynecologist. 
Radiation oncology unit consist of radiation oncologist, physicist, technologist and 
technicians and among other services they also offer brachytherapy. Pathology department 
routinely provide other required service for cancer patient including cytopathology and 
histopathology. The pathology department consists of 4 pathologist, 4 technologists, 1 senior 
technician and 8 technicians. 
Despite having human resources, technical facility for diagnosis and treatment and expert 
manpower the hospital has no organized screening system for the most commonly occurring 
cancer (cervical cancer). Opportunistic cervical cancer screening is provided once a week. 
Cancer awareness and education program is run in out patient department daily to increase 
awareness among patients, visitors and attendants. FM radio stations, cervical cancer 
pamphlets and Pap smear leaflets written in Nepali language were also used for public 
awareness. 
Due to the availability infrastructure for diagnosis and treatment and human resources, 
particularly speaking of Bharatpur, Chitawan where BPKMCH is located it is foreseeable to 
establish an organized Cervical Cancer screening in that area. 
 
Rationale to carry out this study 
However cervical cancer is most frequently occurring malignancy in Nepal, most of the 
studies carried out in Nepal in regards to cervical cancer are hospital based (7, 8) and despite 
extensive literature search, research that assess target women’s awareness and knowledge 
regarding cervical cancer or identifying the determinants of non participation of the target 
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women in cervical cancer screening services were not found. Thus the present study aims at 
identifying determinants of these factors that are necessary for successful cervical cancer 
screening programme in Bharatpur, Nepal.  
 1 
 
Chapter 1 : Review of literature 
1.1 Magnitude of Cervical Cancer Globally 
 
Central and south America, the Caribbean, Sub-Saharan Africa part of Oceana, south and 
south east Asia are the regions with highest incidence rates of cervical cancer-over 30 per 
100,000 women.(9) This shows that Cervical Cancer is an important public health problem 
among these developing countries. Global cancer report, 2003 has stated that the  global 
cancer rate could increase 50% by the year 2020.(10) This statement is further highlighted by 
Peter Boyle the director of International Agency for Research on Cancer (IARC)  in European 
Research Organization on Genital Infection and Neoplasia (EUORGIN) 2004 conference by 
saying “If nothing is done to prevent cervical cancer, there will be one million women 
developing the disease annually by 2050 and also the poorest part of the world will be worst 
affected”.(11) 
At present approximately 1.5 million people women worldwide are living with cervical 
cancer, and based on the natural history of cervical cancer up to 7 million women worldwide, 
may have precancerous condition that need to be identified and treated.(9) 
 
1.2 Patho-physiology of the Cervix 
Cancer of the cervix uteri is the cancer that occurred in the lower one third of uterus and is 
composed of dense fibro muscular tissue lined by two types of epithelium: Squamous 
epithelium and columnar epithelium. Squamous epithelium covers the most of ectocervix and 
vagina. Columnar epithelium lines the cervical canal and extends outward to variable portion 
of ectocervix.The demarcation line between squamous and columnar lining of epithelium is 
termed as squamocolumnar junction (SCJ). The location of the original SCJ varies with the 
woman’s age, hormonal status, history of birth trauma, pregnancy status and use of oral 
contraceptives. 
When exposed to the acidic environment of the vagina, the normal replacement process 
termed, squamous metaplasia takes place and gives rise to new SCJ. The area between the 
new SCJ and original SCJ is termed as transformation zone (TZ). The most abnormal area of 
the cervical TZ are considered as site where potential preinvasive lesion may reside.(12) In the 
presence of persistent Human papilloma virus (HPV) infection or presence of other cofactors, 
the metaplastic squamous cells of  TZ take an abnormal appearance, which is called cervical 
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squamous precancer (dysplasia). These cells later multiply in a disorderly manner typical of 
cancerous change to produce squamous cell cancer.  
Cervical cancer is a progressive disease with histologically detectable pre-invasive stages. 
Mild, moderate, severe dysplasia and carcinoma in situ are four classical categories of non 
invasive neoplasia. The morphological criteria used to differentiate these categories are based 
on degree of epithelial differentiation. Degree of epithelial differentiation becomes 
progressively obvious along a scale from mild dysplasia to carcinoma in situ. 
 
1.3 Terminologies on Epithelial Differentiation 
 
There were different terminology developed in different period of time to define the neopastic 
changes and synonymous terminologies are shown below: 
Dysplasia Original CIN Modified CIN The Bethesda system (TBS) 
Normal Normal Normal Within normal limits, Benign cellular 
changes (Infection or repair) 
Atypia Koilocytic atypia 
Flat condyloma 
Low grade CIN LSIL 
Mild dysplasia  CIN1 Low-grade CIN LSIL 
Moderate dysplasia CIN2 High-grade CIN HSIL 
Severe dysplasia CIN3 High-grade CIN HSIL 
Carcinoma in situ CIN3 High-grade CIN HSIL 
Invasive carcinoma Invasive carcinoma Invasive carcinoma Invasive carcinoma 
 
CIN: Cervical Intraepithelial neoplasia; LSIL: Low-grade squamous intraepithelial lesion; 
HSIL: High-grade squamous intraepithelial lesion; ASCUS: Atypical squamous cells of 
undetermined significance; AGUS: Atypical glandular cells of undetermined significance. 
 
Carcinoma in Situ (CIS) was introduced in 1932 to denote those lesions in which the 
undifferentiated carcinomatous cells involved the full thickness of the epithelium, without 
disruption of basement membrane. The term dysplasia was introduced in the late 1950 to 
designate the cervical epithelial atypia that is intermediate between the normal epithelium and 
CIS. Dysplasia was further categorized into three different groups-mild, moderate and severe 
depending upon the degree of involvement of epithelial thickness by the atypical cells 
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Cervical intraepithelial Neoplasia (CIN) was introduced in 1968 to denote the whole range of 
cellular atypia confined to the epithelium. Increase recognition of pathological changes such 
as koilocytic or condylomatous atypia with HPVinfection around 1980 led to development of 
modified CIN terminology in 1990 and which showed that high grade CIN are considered to 
be true precursor of invasive cervical cancer. 
 In 1988 the US National Cancer institute convened a workshop to propose a new scheme of 
classification for reporting cervical cytology reports and developed the new term the Bethesda 
system(TBS) in1991.This system is also recommended by WHO to report Pap smear.(13) 
 
1.4 The Bethesda System of Reporting Pap Smear 
The main feature of TBS was the creation of term squamous intraepithelial lesion (SIL) and 
two grade scheme consisting of low grade (LSIL) and high grade (HSIL) lesions. TBS 
combines flat condylomatous (HPV) changes and low grade CIN (CIN1) into LSIL, While the 
HSIL encompasses CIN2 and CIN3.The term lesion was used to emphasize that any of the 
morphological changes upon which a diagnosis is based do not necessarily identify neoplastic 
process. TBS was reevaluated and revised in 2001 workshop convened by the National 
Cancer Institute, USA, cosponsored by 44 professional societies representing more than 20 
countries. The reporting categories under the 2001 TBS  includes Negative for intraepithelial 
lesion or malignancy, Squamous cell abnormalities, Glandular cell abnormalities and 
Endometrial cells in a woman over 40 years of age.(14) 
 
1.5 Natural History of Dysplasia 
It now  appears that the direct precursor of cervical cancer is high grade dysplasia, which is 
about a third of instance may progress to cervical cancer over a period of 10 to 15 years, while 
most low grade dysplasia regress spontaneously.(15,16) 
A Meta- analysis of 27,000 women gave the weighted average rates of progression to HSIL 
and invasive cancer at 24 months according to baseline cytological abnormality of ASCUS, 
LSIL and HSIL. This showed that 68.2% of ASCUS, 47.4% of LSIL and 35.0%of HSIL 
regress to normal at 24 months and 7.1% of ASCUS, 20.8% of LSIL progress to HSIL and 
23.4% of HSIL remain persistent. The study also showed that 0.3% of ASCUS, 0.2% of LSIL 
and 1.4% of HSIL progress to cervical cancer at 24 months. (17)  
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1.6 Stages of Cervical Cancer 
According to Federation of gynecology and obstetrics (FIGO) classification, Cervical Cancer 
is classified into stage 1 to 4. (18) The Staging was done based on the presence of cancer that is 
confined to the cervix (stage 1), invading beyond the cervix but not to pelvic wall or lower 
third of vagina (stage 2), extending to pelvic wall or lower third of vagina or causes 
hydronephrosis (stage 3) and extending the bladder or rectal epithelium or beyond the true 
pelvis (stage 4). Treatment ranges from cone biopsy, Loop electrosurgical excision procedure 
(LEEP) or hysterectomy to pre invasive stages and hysterectomy or radiation therapy or 
combination of both depending upon the stage of the disease.5 year survival with optimal 
treatment ranges from 90 to 100% in stage 1A to 0% in stage 4B. Thus the cure rate for 
invasive cervical cancer is closely related to the stage of disease at diagnosis and the 
availability of treatment. (19)  
A study in Iceland has shown that a cervical cancer screening programme helps to reduce 
incidence of stage 2 and more advances stage of cervical cancer. (20)  
A study conducted in Nepal, by Zhang et al. showed that 90% of the invasive cancer is 
squamous cell carcinoma and  most often detected at a very late stage, stage >2. (21) This 
could be attributed to lack of an organized screening system, poor health facilities and the 
poor socioeconomic status of women in Nepal. 
 
1.7 Risk Factors for Cervical Cancer 
The majority of cervical cancer cases are caused by hr-HPV, a sexually transmitted virus that 
infect cells and may result precancerous lesion and invasive cancer. (3,23) Though exposure of 
HPV infection to sexually active women are very common, most cervical abnormalities 
caused by HPV regress themselves and only few progress to high grade CIN or cervical 
cancer. The long duration that takes for manifestation of overt disease from the initial 
infection of HPV showed that other cofactors influence the progression of disease. The 
cofactors include HPV related cofactors: viral type, simultaneous infection with several 
oncogenic types, high virus load, host related cofactors: immune status and parity and 
exogenous cofactors: Tobacco smoking, coinfection with HIV or other sexually transmitted 
agents such as Herpes simplex virus 2(HSV-2), Chlamydia trachomatis and Neisseria 
gonorrhoeae and long term (>5years) use of oral contraceptives. (24)  
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1.8 Preventive Approach to Control Cervical Cancer 
Primary prevention, early detection through increased awareness and organized screening 
programme, diagnosis and treatment are four components of cervical cancer control. 
Progression from cervical lesions to invasive cancer is a slow process and most often it is 
asymptomatic in its early stages. Therefore an early detection and treatment of these 
asymptomatic lesions can only be possible if women are given opportunity to have cervical 
cancer screening at an early stage.  
 
1.8.1 Cervical Cancer Screening 
According to WHO, screening is a public health intervention used on a population at risk, or 
target population to identify individuals with high probability of having or developing a 
disease but not undertaken to diagnose a disease. Thus screening is the process by which a 
test is applied to select out asymptomatic individuals at risk of having or developing a certain 
disease.  
Several tests such as Visual inspection with acetic acid (VIA), Visual inspection with Lugol’s 
iodine (VILI), Human Papilloma virus deoxyribonucleic (HPV DNA) test and Pap smear test 
can be used in screening for cervical cancer. But to date, the Pap smear is the only test that 
has been used in large population for more than 50 years and it has shown tremendous effect 
in reducing incidence and mortality from cervical cancer. According to IARC estimate, 
among well-screened women aged 30-64 years, Pap smear screening prevented 80% of 
cervical cancers. (23) Present HPV DNA test may not be feasible in low resource country due 
to high cost and lack of technical facility and VIA or VILI which has been advocated as 
alternative strategies for screening cervical neoplasia in low resources  country has still not 
developed comparable evidence on their effectiveness and large studies are still underway.(25)  
Though specificity of Pap smear is generally agreed over 90% its limited sensitivity has been 
acknowledged openly and it has been estimated to be range from 50-80%.(26) But this lower 
sensitivity is masked by regular screening, which has cumulative sensitivity of over 90% for 
three successive smear. (27) 
A study conducted in Nordic countries has showed 93% sensitivity of Pap smear test in the 
25-64 year age group at an interval of one year and 73% after 3 years and specificity of 
approximately 98%. Same study also concluded that the sensitivity at 3 years was 91% for 
squamous cell carcinoma and 58% for adeno and adenosquamous carcinoma. (20) A hospital 
based study conducted in one of the laboratories in teaching hospital in Kathmandu also 
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showed significant correlation of Pap smear result with result of histology. The study has 
shown76% sensitivity and 83.3% specificity for diagnosis of benign grade, 60% sensitivity 
and 93.9% specificity for LSIL, 100% sensitivity and 89.5% specificity for HSIL and 100% 
sensitivity and specificity for carcinoma. (28) 
Past failure in cervical cancer screening in developing countries are primarily due to quality 
of screening programme than technological limitation of screening test.(29) This infers that 
shift in paradigmatic focus from technology toward quality is mandatory and more 
fundamental and challenging issue is the organization of the program in its totality. Report of 
WHO consultation also says that the essential element for successful cytology include training 
of the relevant health care professionals, including smear takers, smear reader 
(cytotechnologist and cytopathologist), colposcopist and program managers.(25)  
Screening programme is defined as opportunistic when the initiative to screening is done by 
the person or health care provider without regard of previous screening. Whereas, an 
organized screening is the programme that invites all persons at regular intervals regardless of 
opportunistic screening. According to WHO for a screening programme to be successful, 
following elements must be present :( 13) 
 ♦high coverage (80%) of the population at risk of the disease. 
♦Appropriate follow up and management for those who are positive on screening. 
♦Effective links between programme components (e.g. from screening to diagnosis and 
treatment) 
♦high quality of coverage, screening tests, diagnosis, treatment and follow up. 
♦Adequate resources. 
According to International Union against Cancer (UICC) organized screening is more 
effective than opportunistic screening in reducing the risk of cancer, because of its ability to 
achieve higher compliance by the risk groups and is also more cost effective as it prevents 
over use of services. (30) 
 
1.8.2 Effect of Cervical Cancer Screening in Developed Countries 
 Organized screening programme was started as early as 1949 in British Columbia in Canada. 
By1960 there were screening programme in much of Scandinavia. A sharp decline in the 
incidence rate and mortality rate of cervical cancer was observed in many developed countries 
within the last 40 years due to organized screening program. The Nordic countries are 
exemplary in this respect. Nordic countries (Iceland, Finland, Sweden, Denmark) which have 
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initiated organized screening program much earlier around 1960 showed higher rate of 
reduction in incidence and mortality of cervical cancer, compared to Norway where organized 
screening was initiated much later around 1994. (31, 32) Study conducted in Norway has also 
shown that increase coverage of target population has significant role in reducing invasive 
cervical cancer. (33)  
 
1.8.3 Failure of Cervical Cancer Screening in Developing Countries: 
Despite tremendous positive impact of cervical screening in developed countries, most middle 
income developing countries where the screening program has initiated as early as 1970 such 
as Cuba, Mexico, Colombia etc, have seen no but no substantial decrease in mortality from 
cervical cancer. This is attributed to unrealistic notion of frequent cervical cancer screening 
offer to targeted women of wide range of years (20-65). (34) A study pertaining to African 
country also showed that the existing programs are failing to achieve a major impact due to 
relying on opportunistic screening of relatively young women; lesser target for women in risk 
groups (women in their thirties and fourtees) and low levels of coverage with at least once in 
a lifetime screening for at-risk women. (35) 
 Thus looking back to screening program in most developing and developed countries one can 
conclude that to obtain positive impact on cervical cancer incidence and mortality, efforts 
must be focused on improving screening coverage rates for high risk targeted women. 
However, obtaining high level of coverage is challenging in both developed and developing 
countries. 
In developing countries the barriers to cervical cancer screening uptake include absence of 
knowledge about the disease, lack of familiarity with the concept of preventive health care, 
geographic and economic inaccessibility of services, poor quality of services and lack of 
support from families and communities. (36) Several studies have shown that a lack of 
awareness about cervical cancer and how to prevent it is an important obstacle to improve 
screening coverage. (37, 38, 39, 40)  
A big case control study conducted in Maharashtra, western India including 97000 women in 
cases and 79,000 women in control group showed that efforts to improve awareness of the 
population has resulted in early detection of and improved survival from cervical cancer.(34) 
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Chapter 2 :Objectives of the study 
2.1 General Objectives: 
2.1.1 To study a cervical cancer program and its ability to detect a proportion of possible 
abnormal smear in a female population in Nepal. 
2.1.2 To assess women’s barrier for attending cervical cancer screening in Nepal. 
2.2 Specific Objectives: 
 
2.2.1 To estimate the prevalence of abnormal Pap smears finding among women in Bharatpur. 
 
2.2.2 To assess women with at least one previous Pap smear among married women aged 30-
59 in Bharatpur. 
 
2.2.3 To assess women’s awareness about cervical cancer among married women in 
Bharatpur. 
 
2.2.4 To assess knowledge about cervical cancer among married women aged 30-59 in 
Bharatpur. 
 
2.2.5 To identify the barriers that hinders women to participate in a cervical cancer screening 
clinic. 
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Chapter 3: Methodology 
3.1 Study Design: 
A community based cross sectional study was carried out among 1547 married women aged 
15-59 living in Bharatpur municipality of Chitawan district in Nepal. 
Structured interview questionnaire were used for data collection. However, in-depth 
information regarding awareness and knowledge of cervical cancer, barriers to utilization of 
preventive health services and information regarding sensitive issues such as multiple sexual 
partner can be identified in more detail through either using open ended questionnaire or 
qualitative study such as focus group discussion, participatory observation etc but due to 
limitation of time the study was not carried out in such a way and we acknowledged for that.  
 
3.2 Study Area: 
Chitawan district consist of 13 county with, 36 village development committee and 2 
municipality with total population of 4,69,699.The total area is 2238.39 square kilometer and 
among them 40.60% of land is occupied by national park,4.58% by urban and 54.82% by 
rural area. 
This district lies in the center of the main East -West highway of the country, 310 meters 
above the sea level and is approximately 150 km south west from Kathmandu, the capital and 
takes about 10 minutes by air and four hours by road. 
Bharatpur municipality occupies 68.77 square kilometer of the total land of Chitawan. 
It consist of fourteen wards with total population of 54,670 and among them 26289(48%) are 
female with mixed population of urban and rural area. (4)  
The prime reason that Bharatpur municipality, Chitawan is chosen for this study is because of 
BPKMCH is situated here. Thus even after the completion of the study those participant who 
will be diagnosed to have abnormal smear such as ASCUS, LSIL and HSIL who need further 
diagnosis and management can be referred to this hospital and treatment will be provided to 
those who need according to hospital protocol. 
For our study, ward number 11 of Bharatpur municipality was chosen. This ward consists of 
2326 households with total population of 10,740 (5475 male and 5265 female). Uniqueness of 
this ward is that it consists of household from slum area and from non slum area and also 
inhabited by marginalized ethnic groups such as Darai and Kumal. (4)  Thus we tried to get 
good representation of total population.  
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A household from Slum area 
 
3.3 Study Populations: 
3.3.1 Sample size for the Proposed Study: 
Based on population based study carried out between BPKMCH and IARC in 2003, (5) the 
prevalence of precancerous lesion for cervical cancer was found to be 2.5%. Sample size of 
our study was calculated based on this previous prevalence in this area. 
The minimum number of participants required for this study was calculated using the formula 
 N= R/E2; Where N = minimum number required, R= rate of prevalence, E= Standard error 
Standard error was calculated to be 0.5/100, considering the expected prevalence range from 
1.5 to 3.5%. 
Rate= 2.5/100= 0.025 
Error= 0.5/100= 0.005 
N= 0.025/ (0.005)2 = 1000 participants. 
1000 is the required sample size to estimate the prevalence of 1.5 to 3% of abnormal cervical 
smear detection on cervical cancer screening. But considering possible decrease response rate 
or refusal to undergo gynecological examination we increased our sample size by 55%. Thus 
we took total of 1547 married women in our study. 
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3.3.2 Sample Population 
Married women aged 15.-59 residing in Ganeshthan, Muktinagar, Naurange and Bhojad from 
ward number 11, Bharatpur municipality were chosen. 
1000 is the required sample size to estimate the prevalence of 1.5 to 3% of abnormal cervical 
smear detection on cervical cancer screening. But considering possible decrease response rate 
or refusal to undergo gynecological examination we increased our sample size by 55%. Thus 
we took total of 1547 married women in our study. 
 
3.3.3 Sampling Process 
Though it is ideal to do the individual random sampling process we found its difficult to 
randomize individual when considering the providing service like cervical cancer screening. 
Thus instead we did cluster randomization and thus selected Ganeshthan, Bhojad, 
Muktinagar, Naurange and Lama Tole from ward number 11. 
 
3.4 Inclusion Criteria 
Married women aged 15-59 from Ganeshthan, Muktinagar, Naurange and Bhojad of ward 
number 11, Bharatpur municipality. 
 
3.5 Exclusion Criteria 
♦ had undergone hysterectomy for any cause.  
♦ had undergone cervical cancer treatment or those who are under treatment of cervical   
cancer 
♦ those that was severely ill to come to the screening clinic.  
♦ those that was pregnant at the time of our study. 
♦ those who did not gave consent to participate in the study.  
♦ those who are heavily menstruating (called for later date, after 2 weeks)  
 
3.6 Research Team at Field Work 
Research team at the field consists of following persons: 
♦ Two female interviewers with collage degree. 
♦ Two Female Community Health Volunteers (FCHV) that are also lives in our study site. 
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♦ A smear taker nurse with 20 years experience working in family planning and with very 
good experience in speculum examination and smear collection. 
♦ An assistant nurse.  
♦ A medical doctor with two years training in obstetrics and gynecology department, 
♦ Myself, the principal investigator with eight years experience working in various medical 
field after graduation. 
♦ An experienced medical technologist who deals entire Pap staining in BPKMCH. 
♦ An experienced pathologist from BPKMCH who had also done her doctorate thesis in 
Pap smear.  
♦ A gynecologist from BPKMCH to deal women with abnormal smear for further 
management and treatment. 
♦ Director of BPKMCH to supervise the project work. 
♦ Two data entry personnel with good technical skills in computer. 
 
3.7 Training for Field Workers 
Training was basically given to interviewers, FCHV and data entry personnel and nurse. All 
of them were given two lecture class about what cervical cancer is, its causes and risk factor 
and measures to prevent cervical cancer, the interviewer were further explained about each 
question and taught how to conduct interviews and how to report exactly how the respondent 
will answer, to keep the confidentiality of the information that they will gather during field 
work and to remain non judgmental for participants response. FCHV were familiarized about 
the house mapping done by the interviewer how to record the invitation card and logbook. 
Data entry personnel were also explained about how to record exactly as it is in the 
questionnaire in the excel data base. 
Several meetings were also held between research team for discussion of problems, 
maintaining good morale. From the very early part of study, before starting the actual field 
work our collaborator from IARC Dr. Silvia Franceschi came to Nepal and guided us how to 
run this project and at the start of project Dr. Gary Clifford spent one week for actual data 
collection in the field and data management. 
 
3.8. House Mapping 
Given the fact that the demographic distribution of the population is not well known initial  
survey was done every household in ward number 11 and questionnaire were asked how 
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many married women aged 15-59 lives in each household and at the same time numbering of 
the house were also done by the permanent marker pen. The house mapping were done by the 
two personnel who were interviewer in our research team and after completion of the house 
mapping community health volunteers who will be recruiting these women were also 
familiarized about the house mapping. The reason that two  interviewer were employed in 
house mapping instead of FCHV who actually recruit that participant was because the 
interviewer are more efficient in doing this task since they are younger, energetic and also 
know how to ride bicycle. During this time women in these household were also asked about 
their willingness to participate cervical cancer screening and very good response was 
achieved. 
 
 
 
Interviewer informing about the objective of the study at the time of house mapping. 
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Interviewer writing household number with permanent marker pen. 
 
3.9 Pilot Study 
Pilot study was conducted for 10 women. At this time we assessed how many will actually 
undergo gynecological examination, assessed expected time to examine each patient 
including signing of consent form, interview and gynecological examination. Thus number of 
participant that can be called in a day was determined. Data collection forms were also 
assessed to see if it can be filled without any confusion. Questionnaires were assessed if it can 
be easily understood by participant and reliability of answer was checked by asking same 
questionnaire by two interviewers to the same informant and comparing the result. After the 
pilot study following changes were made: 
1. Initial thought of inviting 10 women per day was changed to inviting 20-30 women per 
day. 
2. Questionnaire that includes husbands occupation with army was removed since all women 
at that time did not want to disclose if their husbands are working in the army. From this we 
derived that this question was not appropriate at that situation since there was internal conflict 
going on in our whole country and holding position in either form of army were target for 
each other. 
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3. Initially when we invite participants we gave them clinic address and told to come on their 
own and we will be reimbursing the transportation cost but when we did this some of the 
participants did not come and some participants came very late when the clinic is already 
closed. So we decided to accompany the invited women by a CHV and bring them to the 
clinic in a group at one time, preferably between 10-12AM. 
4. For Pap smear report distribution we thought of distributing by CHV but many women 
were found not to receive their report on time or some ever. Thus we decided to call the 
women by themselves to the screening clinic after 4 to 6 week for follow up of their result. 
 
3.10 Data Collection 
3.10.1 Recruitment of the participants 
Two FCHV who also lives in ward number 11 were assigned to invite all eligible women in 
these areas, through door to door personal visit 1 day before the appointment for screening. 
Each day each CHV visited 10-20 household and distributed the invitation card to those 
eligible women who were willing to participate. Those women who accept to get the 
invitation card were assigned a subject identification number.This number is composed of study 
identifier number (142) followed by the individuals code (4 digits).This information was transferred to 
invitation card and invitation register including household number, address, full name and 
age.Next morning   each CHV went to these women to bring them to the clinic altogether. 
Those who got the invitation card but did not participate in the study were recorded as non 
participant and reason for non participation in the study were asked.  
Upon arrival at the study clinic, women will be checked with the Invitation Register, after which 
information will be given to groups of up to 10-20 women on the study objectives and the benefits of 
screening. All participants will be asked to sign an informed consent form before the clinical 
examination and interview. If a woman accepts to either give undergo gynaecological examination, or 
just respond questionnaire were included in the study.  
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Principal investigator explaining study objectives to the participant 
before signing informed consent form. 
 
Field research team with the mothers group “Ama Samuha” 
and teachers from the study area. 
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3.10.2 Face to Face Interview 
The questionnaire were adapted from previous study questionnaire used for Women’s health 
survey in Norway and questionnaire used for assessment of reproductive morbidity in Nepal 
conducted by united nation population fund, German agency for technical cooperation and 
ministry of health, Nepal.(41) 
Question prepared in English were converted into Nepali language and these sets of questions 
converted into English and Nepali were further checked by 3 Nepalese doctors and concluded 
exact translation.  
After an informed consent has been signed an interview about socio-demographic, reproductive health 
characteristics of participant and their awareness, knowledge and barriers to seek preventive health 
service for cervical cancer were administered to all participants by female interviewers.  
Each woman was interviewed in a confidential manner in complete privacy in a separate room. 
At the end of day all questionnaire were checked to see the completeness by finding missing answer.   
 
Tallying similarity of subject identification number in all the forms used  
and checking completeness of questionnaire. 
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3.10.3 Pap Smear 
3.10.3.1 Cervical Smear Collection: 
Either senior nurse or medical doctor was assigned for collecting smear. After the application 
of  speculum smear was collected according to standard protocol using an extended tip plastic 
Ayre spatula and  inserting it to the os and rotating it through the full circle(360 degrees).(12) 
 Both sides of spatula were smeared onto the frosted glass slide with one or two careful 
swipes. Labeling of the slide was done by diamond marker pen using same subject 
identification number which was used in invitation card and questionnaire. Fixation of slides 
was done immediately by immersing the slide in 95% ethanol for 20-30 minutes and then air 
dried. All this procedure was carried out taking into consideration of aseptic precaution. 
Women with history of discharge with abnormal finding on gynecological examination were 
referred by the nurse to the medical doctor and given one course of antibiotics according to 
WHO guidelines. (13) 
Details concerning the visual status of cervix and all clinical diagnostic work up procedures 
were recorded in the clinical examination section of the questionnaire.  
 
Performing speculum examination and collecting cervical specimen  
with extended tip Ayer’s spatula and endocerical brush. 
(Picture taken with the permission from the participant) 
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Wart (cauliflower like overgrowth) around the vulva and discharge per vagina:  
Possible HPV infection. 
(Picture taken with the permission from the participant) 
 
3.10.3.2 Laboratory test: 
After fixing the slides at the screening clinic, they were sent to the pathology laboratory for 
Pap staining and reporting. Slides were sent in batches about 150 slides every week. All the 
reading of slides was done by single qualified pathologist, according to the Bethesda system. 
 
3.11 Quality Control of the Laboratory Test: 
 However quality assurance is crucial in cytology reporting, we would like to acknowledge 
that we failed to do quality control of the reporting of slides in this study and the reason are as 
follows: 
1. BPKMCH is the biggest cancer referral center in Nepal and there is no reference 
laboratory available in the country. 
2. Even review of slides by the other pathologist during this  could not be done due to 
some pathologist who went to study leave and other available pathologist in the 
department are busy to cope with regular flow of the patient in the hospital. 
Though quality control of the Pap smear reporting was not done but high sensitivity and               
specificity of the result can be assured by the background of the Pathologist who had done 
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also doctorate thesis on Pap smear and due to her work experience in Cancer hospital where 
cervical cancer patient are referred highest in number, however exact data is not available. 
High quality staining of Pap smear can be assured by selecting a qualified technologist who 
also does all Pap staining in the hospital. Adequate collection of cellular material from 
transformation zone are maintained by using extended tip Ayre spatula supplied by IARC 
France and Cancer Registry, Norway. The adequacy of smear collection could also be verified 
by very low percentage (0.8% of the total smear taken) of repeat smear advised by the 
pathologist due to unsatisfactory smear and most of these occurred among postmenopausal 
women and in these case due to physiological changes the transformation zone moves in to 
the endo-cervical canal and which makes difficulty taking proper smear. 
 
3.12 Data Management 
A completeness of questionnaire were checked by missing answer and proper matching of 
subject identification number in all forms used and specimen collected were checked at the 
end of the day after data collection. Double-entry of the data from questionnaires was 
performed on a regular basis, almost everyday at the end of data collection by two data entry 
personnel on Excel (registr.Xls).  When Pap smear results were available they were also 
recorded to database. A copy of the result was provided to the participant themselves and a 
copy of the result was kept in BPKMCH pathology department for future reference. 
 
3.13 Data Analysis 
Data checking were done by comparing the data files entered by two different personnel to 
reveal if there is any difference between the two files by mistyping. Most of the variables that 
we have used on our study were categorical data. Thus there were a fixed number of pre-
specified values and question that does not apply are coded as 88 and question that was not 
answered are coded as 99. All erroneous values aside from these specified values are checked 
and correction was done. 
Data recorded on Excel (registr.Xls) was transformed into Statistical program for social 
sciences (SPSS) program. Data screening were done by producing a histogram and scatter 
plot of most of the variable to see its normality, average value, outliers and missing values. 
Descriptive statistics for categorical variable are obtained by frequencies analysis and mean, 
median and standard deviation from continuous data are obtained by descriptive analysis. To 
explore the relationship between different variable and to assess the proportion into different 
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groups Chi-square test was performed. All analysis was performed using SPSS for Windows 
(version 12). (42) 
 
3.14 Ethical Consideration 
Since this study is part of the bigger study conducted to identify the prevalence of HPV in 
Bharatpur, in which I myself was the principal investigator, ethical clearance was sought from 
Nepal Health Research council ethical review board to carry out the Human Papilloma virus 
study in Bharatpur and to take out the specimen out of the country to perform molecular test. 
However it was also clearly mentioned that while taking sample for Human Papilloma virus 
these women will also offered Pap smear test to find out abnormal smear from these women 
and information will be collected from them regarding risk factor for cervical cancer, cervical 
cancer awareness and knowledge and barriers for participating in the screening clinic by using 
some questionnaire. 
 
3.14.1 Scientific Merit 
As many studies has proven that cervical cancer screening is cost effective than treating 
invasive cancer and also organized screening program is more cost effective compared to 
opportunistic screening service.(12) Therefore this study will help health ministry and 
governing body to formulate a policy to invest on preventive health, specially in cervical 
cancer which  has multi dimensional, socio-psychological and economic impact not only on 
woman’s life but for the whole family. 
 
3.14.2 Informed Consent 
Participants name and address record were recorded on registration log book so that when the 
results were available they could be easily traced out to handover the result. Beside this 
participants name and address did not reflect in any other form used, instead each participant 
was given a identity number to mask the true identity. The same identity number was used on 
invitation card, questionnaire, and consent form and on Pap smear slides and other specimen 
collected and Pap smear result. Participants were ensured that the research team guarantees 
the anonymity of the survey and the confidentiality of the information provided by them. 
Participants were given standard information of the purpose and procedure of the study. They 
were also told that their participation in this study is their own free will and that they were 
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free to respond either only questionnaire or only undergo gynecological examination or refuse 
both without jeopardizing their treatment at the clinic. 
Participants were also provided antibiotics for free for suspicious genital infection detected at 
the time of screening. All participants who had Pap smear were given their result and women 
with abnormal smear (ASCUS and LSIL) are advised for repeat cervical smear after 6 months 
and HSIL were advised for immediate biopsy. They were also told that these repeat cervical 
smears, biopsy will be free of cost and treatment will be provided in BPKMCH according to 
hospital protocol, for those who need.  
 
3.15 Time Allocated for Field Study 
House to house survey:  2 week 
Meeting with research team to discuss about the project: 1 week 
Training for interviewer and assistant: 1 week 
Change questionnaire written in English into Nepali language: 1 week 
Pilot study: 2 week 
Data collection: 3 month (12 weeks) 
Miscellaneous activities: 1 month (4 weeks) 
Total duration spent for data collection: 23 weeks= 6 months 
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Chapter 4 Result: Text, Tables and graphs 
 
Table 1. Socio-Demographic Characteristics of Study Population 
Total number of participants   1033(70%) 
Participants with Hindu religion 
Participants with Buddhist religion 
Participants with Christian religion 
Participants with Moslem religion 
871(84.3%) 
135(13.1%) 
  24(2.3%) 
    3(0.3%) 
 
Mean age of the participants (standard 
deviation) 
Minimum-Maximum age of the participant 
 
34.3(10.416) 
 
16-59 
Marital status: 
Married                                                                                 
Separated or divorced 
Widow 
Remarried 
 
 
931(90.1%) 
  26(2.5%) 
  31(3.0%) 
  45(4.4%) 
Participant’s household From Slum area: 
Participants household from non slum area 
 
540(52.3%) 
493(47.7%) 
Participants with history of smoking: 
Participants who are Past smoker 
 
127(12.3%) 
  78(7.6%) 
Participants occupation: 
unemployed 
Housewife 
Labour worker 
Vegetable seller/shopkeeper 
Clerical work 
Higher level job 
 
  55(5.3%) 
773(74.8%) 
105(10.2%) 
  61(5.9%) 
  36(3.5%) 
    3(0.3%) 
 
Education: 
Illiterate 
Primary 
Secondary 
Completed high school 
Higher degree 
 
463(44.8%) 
184(17.8%) 
231(22.4%) 
76(7.4%) 
79 (7.6%) 
 
Table 1 shows that 1033 women with mean age of 34.3 with minimum age of16 to maximum 
of 59 have participated in this study and 84.3% of them are Hindu, 44.8% are illiterate, 74.8% 
are housewife, 2.5% &4.4% divorce or separation rate and remarries rate respectively, 52.3% 
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are from slum area and 47.7% are from non slum area and 12.3% of women are current 
smoker.    
Table 2. Characteristics of Participant’s Husband in Study Population 
 
Table 2.1 Husbands Occupation 
 
Occupation Number (n) percentage 
Unemployed 94   
 
9.1 
Farmer 
 
59  
 
5.7 
Labour worker 280 
 
27.1 
Shopkeeper 
 
86 
 
8.3 
Clerical work 
 
127 
 
12.3 
Higher level job 
 
35 
 
3.4 
Migrant worker 
 
223 
 
21.6 
Driver 29 
 
2.8 
Total 1033 100 
 
Table 2.1 Highest proportion (27.1%) of the participants husband were found to be labour 
worker, followed by 21.6% are migrant worker,12.3% clerical work, 9.1% unemployed,8.3% 
shopkeeper, 5.7% farmer, 3.4% higher level job and 2.8% are driver.  
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Table 2.2 Husbands extramarital affair reported by the participant 
 
 Variable for husband’s extramarital     affair Number(n) percentage 
Before marriage: 
Participant responded yes 
Participants responded no 
Participants responded don’t know 
Participants do not want to reply 
 
 
235 
738 
  33 
  27 
 
22.7 
71.4 
  3.2 
  2.6 
During marriage: 
Participant responded yes 
Participants responded no 
Participants responded don’t know 
Participants do not want to reply 
 
 
166 
801 
  38 
  28 
 
16.1 
77.5 
  3.7 
  2.7 
Husbands having other wife or cohabitant: 
Participants responded yes 
Participants responded no 
Participants responded don’t know 
Participants do not want to reply 
 
 
276 
695 
  33 
  29 
 
26.7 
67.3 
  3.2 
  2.8 
Husbands having children from other woman 
or wife: 
Participants responded yes 
Participants responded no 
Participants responded don’t know 
Participants do not want to reply 
 
 
166 
803 
  35 
  29 
 
 
16.1 
77.7 
  3.4 
  2.8 
 
Table 2.2 shows that26.7% of their husband has other wife or cohabitant and among them 
 22.7% of their husband had extramarital affair before marriage and 16.1% had extramarital 
affair during marriage. Similarity in percentage of husband with extramarital affair during 
marriage and husband having children from other wife or cohabitant is also noted. Few 
percentages of women are not aware about it and few does not want to disclose this 
information to us. 
 
Table 2.3 Husbands currently living with participant 
 
Husband where about  Number (n) Percentages 
Husbands currently living with 
participants 
 619 
 
 59.9 
 
Husband currently living 
somewhere else 
 384  37.2 
Missing    30    2.9 
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Total  1033   100 
 
Table 2.3 show that 37.2% of their husbands were found to live somewhere else and 59.9% 
are currently living together. 2.9% of missing information for this variable represents the 
women whose marital status is widow.  
3. Reproductive Health Characteristics of Participants in the Study 
Population. 
 
Table 3.1 General Reproductive Health Characteristics 
 
Mean age at marriage (SD years)  
Minimum- maximum age at marriage 
17.1 (3.3) 
5-31 
Mean age at first sex(SD years) 
Minimum-Maximum age at first sex 
 
17.4(3.1) 
8-32 
Median age at 1st child birth, median (interquartile range years) 
Minimum-maximum 
 
19 (4) 
14-40 
Mean for Parity of the participant, (SD number of parity) 
Minimum-maximum 
 
 
2.6 (1.5) 
0-11 
Mean age at menarche(SD years) 
Minimum- Maximum 
 
14.1(1.6) 
11-19 
Mean age at menopause(SD years) 
Number of participant with menopausal age (n) 
Minimum-maximum 
46.8 (2.1) 
94 
31-56 
 
Table 3.1 shows that very early age at marry with mean of 17.1 with SD of 3.3 years. Mean 
age at marry is almost same as mean age at first sex 17.4 with SD of 3.1years. Median age at 
first childbirth is 19 with inter quartile range of 4 years and mean for parity is 2.6 with SD of 
1.5. Mean age at menarche and menopause are 14.1 with SD of 1.6 years and &46.8 with SD 
of 2.1respectively. 
 
Table 3.2 Lifetime number of sexual partner 
 
Lifetime number of sexual partner Frequency (n) Percentages 
Only one    901 87.2 
More than one   132 12.8 
Total 1033 100 
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Table 3.2 shows that 87.2% of our participants had monogamous relationship. 
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Table 3.3 Contraceptive practice:hormonal contraceptives 
Variable for hormonal contraceptives Frequency    (n) Percentages 
Current pill use 
Pills used in past 
Never used Pill 
Total  
 
    85 
  158 
  790 
1033 
  8.2 
15.3 
76.5 
100 
Current Depo-Provera use 
Past Depo-Provera use 
Never used injectables 
Total  
   94 
 242 
 697 
1033 
  9.1 
23.4 
67.5 
100 
 
In our study we have found most common mode of contraceptives that the women have used 
is Depo-Provera injection (32.5%), followed by Use of pills (23.5%). Among them women 
who are currently using pills and injectables were found to be 8.2% and 9.1% respectively.  
 
Table 3.4 Contraceptive practice:Condom 
 
Participants with use of condom 
 
Frequency    (n) Percentages 
Current use 
 
  42   4.1 
Used only in the past 
 
118 11.4 
Never used condom 
 
873 84.5 
Total  1033 100 
 
We have found very less use of condom among married couple. Only 4.1% reported of using 
condom regularly and 84.5% have never used condom.   
 
 
Table 3.5 Participants with signs and symptoms of sexually transmitted 
disease 
Participants with abnormal vaginal discharge 
 
516(50%) 
 
Participants with genital sore or ulcer 452(43.8%) 
Participants with genital wart 207(20%) 
 
Table 3.5 shows that highest proportion of participant 50% reported to have abnormal vaginal 
discharge, followed by 43.8% with genital sore or ulcer and 20% with genital wart.  
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Table 4. Proportion of women who had at least one Pap test within age 
group 16-59 
Age group Never had Pap test 
   N (%) 
At least one Pap test 
    N (%) 
Total 
 N (%) 
16-19   46 (74.1) 16 (25.8)   62 (100) 
20-24 114 (73.1) 42 (26.9) 156 (100) 
25-29 117 (66.4) 59 (35.5) 176 (100) 
30-34   88 (57.8) 64 (42.1) 152 (100) 
35-39  76 (50) 76 (50) 152 (100) 
40-44 74 (52.1) 68 (47.8) 142 (100) 
45-49 46 (49.4) 47 (50.5)   93 (100) 
50-54 39 (69.6) 17 (30.3)   56 (100) 
55-59 28 (63.6) 16 (36.3)   44 (100) 
    
Total 628 (60.8) 405 (39.2) 1033 (100) 
 
 
 
 
Among the 1033 participant, 405 had previous pap a least once. Among them 29% belongs to age 
group 16-29, 46.6% with age group 30-44 and 42% with age group 45-59.  
 
 
Table 5. Pap smear result detected from this study  
 
Pap smear result   Participant’s age into 3 categories Total 
   
Percentages 
  15-29   30-44   45-59 
Normal    290  343  143 776 79.4 
Inflammatory     62   74    22 158 16.2 
ASC-US     12     9     6   27   2.8 
ASC-H       1     0     0     1   0.1 
LSIL       1     1     0     2   0.2 
HSIL       1     3     1     5   0.5 
Unsatisfactory       1     2     5     8   0.8 
Total N (%)   368 432 177 977 100 
 
Chi-Square Tests
36,385a 8 ,000
36,886 8 ,000
12,856 1 ,000
1033
Pearson Chi-Square
Likelihood Ratio
Linear-by-Linear
Assoc iation
N of Valid Cases
Value df
Asymp. Sig.
(2-sided)
0 cells  (,0%) have expected count less than 5. The
minimum expected count is  17,25.
a. 
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ASC: Atypical squamous cells 
ASC-H: Atypical squamous cells of high-grade. 
ASCUS: Atypical squamous cell of undetermined significance. 
LSIL: Low grade squamous intraepithelial lesion. 
HSIL: High grade squamous intraepithelial lesion. 
 
Prevalence: 
977 of 1033 participants had a Pap smear. 79.42% of Pap smear was found to be normal and 
16.2% were normal but inflammatory. 
Prevalence of different degree of abnormal cervical smear using TBS is as follows: 
ASC: 28/977× 1000 = 2.86%= 28 per 1000 population. 
(Out of 28 cases of ASC that was reported in our study 27(96.4%) of them are ASCUS and 
only 1(3.6%) is ASC-H) 
LSIL:   2/977 × 1000 = 0.2%=2 per 1000 population. 
HSIL: 5/977 × 1000 = 0.5%= 5per 1000 population. 
For prevalence of different grades of abnormal cervical smear: 
Total prevalence of ASC, LSIL and HSIL are taken, which is equivalent to 3.56 % = 35/1000. 
 
 
Table 5.1 Proportion of Squamous Cell Abnormalities 
 
    Participant’s Age group Proportion of Squamous Cell  
    Abnormalities N (%) 
                  
               16-29 
 
             15 (42.9) 
             30-44 
 
             13( 37.1) 
             45-59 
 
               7 (20.0) 
     Total (16-59) 
 
             35  (100) 
 
As shown in table 5.1, when we grouped ASC, LSIL and HSIL into abnormal squamous cell 
abnormalities, the proportion of abnormal cervical smear were found to be highest in age 
group 15-29 followed by 30-44 and least in 45-59. However overall squamous cell 
abnormalities is found in women aged 15-29, 60 %( 3/5) of HSIL is found in women aged 30-
44. This makes this age group more likely of target group for cervical cancer screening.  
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Table 6. Participants refusal for having Pap smear in this cervical cancer 
screening clinic. 
 
Reason for not having Pap smear Frequency Percent 
Fear of being diagnosed as cancer 17 30.4% 
Ashamed of having gynaecological examination 23 41.1% 
Having heavy menstruation 7 12.5% 
Recently had Pap test 9 16.0% 
Total 56 100.% 
 
Total of 1033 participant, 977 had Pap smear test and 56 refused the test. Out of them 
41.1%are ashamed of having gynaecological examination, 29% having fear of being 
diagnosed as cancer, 15.8%had recent Pap test and 12.5% are having heavy menstruation but 
they did not return for follow up test. 
 
Table 7. Different Modes of Information Dissemination System used to 
Increase Cervical Cancer Awareness in Bharatpur, Nepal 
 
Among 1033 total participant 608(58.9%) had claimed that they have never heard about 
cervical cancer. 
 
.                Information dissemination system 
 
Health 
worker 
N (%) 
Relative/family/friends 
     N (%) 
Mass media 
  N (%) 
Response from the remaining 425 
participants when asked about the 
information dissemination system from 
which they have acquired Knowledge 
about cervical cancer. 
 
 
202 (47.5) 
 
 
328 (77.1) 
 
 
332(78.1) 
 
Out of 425 who have heard of cervical cancer, 78.1% reported that they have heard through 
mass media, 77.1% through relative/ family/ friends and 47.5% through health worker. This 
shows that health workers role for disseminating information of cervical cancer was found 
less compared to mass media and social networks such as family, friends and   relatives.  
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Table 8.  Cross table of  variable ever heard about cervical 
 cancer  versus ever been to School  
 
Awareness of 
cervical cancer  
       Ever been to School Total 
 
N (%) 
 Yes 
N (%) 
No 
N (%) 
Ever heard of 
cervical cancer  254(45.8 ) 169 (35.4) 423 (40.9) 
Never heard of 
cervical cancer  301(54.2 ) 309 (64.6) 610 (59.1) 
Total  555 (100) 478 (100) 1033 (100) 
 
 
Chi-Square Tests 
 
  Value df 
Asymp. Sig. 
(2-sided) 
Exact Sig. 
(2-sided) 
Exact Sig. 
(1-sided) 
Pearson Chi-Square 
 11,510(b) 1 ,001     
 
A Computed only for a 2x2 table 
 
B 0 cells (, 0%) have expected count less than 5. The minimum expected count is 195, 73. 
 
Table 8 shows that 45.8% of women who have ever been to school have heard about cervical 
cancer compared to only 35.4% of women who have never been to School. This different rate 
of women who have heard of cervical cancer in two different groups of those who have ever 
been to school and never been to school is significant with P value of .001.  
Table 9. Proportion of women who had Previous Pap smear among those 
who were aware of cervical cancer versus those women who were not aware 
of cervical cancer. 
  
Previous Pap smear 
taken category 
          Cervical cancer awareness  Total 
 N (%) Ever heard about 
cervical cancer  
     N (%) 
Never heard about 
cervical cancer 
    N (%) 
Not had previous Pap 
smear 
186 (44) 442 (72.4) 628 (60.8) 
Had previous Pap 
smear 
237 (56) 168 (27.5) 405 (39.2) 
Total  423 (100) 610 (100) 1033 (100) 
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Table 9 shows that 237(56.5%) of women who have heard of cervical cancer had 
Pap smear compared to only 168(27.5%). This means that there is 2 times more 
likely chance of having Pap smear taken to those women who have heard of cervical 
cancer compared to those who have never heard of cervical cancer. This difference 
is significant with P value of 0.000. 
 
 
 
Table 10. Proportion of women who are aware of cervical cancer among 
different level of schooling 
 
Level of 
Schooling 
Awareness about cervical cancer  
 
Total  
N (%) 
Aware 
N (%) 
 
Not Aware 
N (%) 
Illiterate 160 (34.6) 
 
303 (65.4) 463 (44.8) 
Primary   70 (38) 
 
114 (62) 184 (17.8) 
Secondary 100 (43.3) 
 
131 (56.7) 231 (22.4) 
Completed high 
school or higher 
degree 
 
  93 (60)  62 (40) 155 (15) 
Total 423 (40.9) 610 (59.1) 1033 (100) 
 
 
 
 
 
 
Chi-Square Tests
85,047b 1 ,000
83,856 1 ,000
85,232 1 ,000
,000 ,000
84,965 1 ,000
1033
Pearson Chi-Square
Continuity Correctiona
Likelihood Ratio
Fisher's Exact Test
Linear-by-Linear
Association
N of Valid Cases
Value df
Asymp. Sig.
(2-sided)
Exact Sig.
(2-sided)
Exact Sig.
(1-sided)
Computed only for a 2x2 tablea. 
0 cells (,0%) have expected count less  than 5. The minimum expected count is
165,84.
b. 
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 Chi-Square Tests 
 
  Value df 
Asymp. Sig. 
(2-sided) 
Pearson Chi-Square 
 32,463(a) 4 ,000 
a  0 cells (,0%) have expected count less than 5. The minimum expected count is 31,12. 
 
Table 10 shows that there is increase proportion of women with awareness of cervical cancer 
as education level increases from primary to completed high school. This difference in 
proportion of women in different groups of education level is significant with Chi-square 
value of P=0.000.  
 
 
Table11. Participant’s knowledge regarding cervical cancer 
 
Variables used to assess 
Cervical cancer 
knowledge 
 
      Response from participants 
 
Yes 
N (%) 
No 
N (%) 
I don’t know 
N (%) 
Total 
N (%) 
 
Preventable 
 
269 (26) 
 
 
90(8.7) 
  
 
674(65.2) 
 
 
1033(100)  
 
Treatable 
 
255(24.7) 
 
 
94(9.1) 
 
 
684(66.2) 
 
 
1033(100) 
 
 
Table 11 shows that only 26% of the participant knows that cervical cancer is preventable if 
diagnosed early course of disease and 24.7% of the participant knows that cervical cancer is 
treatable if diagnosed early course of disease. 
 
 
Table 12. Number of participant versus non participant in this study 
 
Total study population
1033 66,8 66,8 66,8
514 33,2 33,2 100,0
1547 100,0 100,0
participant
non participant
Total
Valid
Frequency Percent Valid Percent
Cumulative
Percent
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 This table shows that out of 1547 total study population 514(33.2%) are non participant. 
 
 
Table13. Distribution of household of study population located at slum area 
versus non slum area 
 
  
This table shows that in our study participant from slum and non slum are almost equally 
represented with 50.8% household from non slum area versus 49.2% household from slum 
area. 
 
 
 
Table 14.distribution of household of non participant in slum area versus 
non slum area 
 
This table shows that 365(71%) of non participants are from non slum area 
compared to 149 (29%) from slum area. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Distribution of household of study population
786 50,8 50,8 50,8
761 49,2 49,2 100,0
1547 100,0 100,0
not from slum area
from slum area
Total
Valid
Frequency Percent Valid Percent
Cumulative
Percent
Household distribution of non participant
365 71,0 71,0 71,0
149 29,0 29,0 100,0
514 100,0 100,0
not from slum area
from slum area
Total
Valid
Frequency Percent Valid Percent
Cumulative
Percent
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Graph 1.Distribution of non participant according to age group 
 
 
 
  
The graph shows that highest proportion of non participant are from two extreme age groups 
(15-19 and 54-59).This is the usual trend observed in many other studies also when it comes to 
participants age versus non participant rate. 
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Table 15. Reasons for non participant. 
 
                           Reasons  Frequency 
I feel okay, no need to have gynaecological examination 
 
196(38.1%) 
Lack of time  
 
152(29.6%) 
Lack of permission from husband or in-laws 
 
63(12.3%) 
Too sick to come to screening clinic 
 
44(8.6%) 
Ashamed to have gynaecological examination 
 
32(6.2%) 
Fear of having gynaecological examination 
 
27(5.3%) 
Total 514(100%) 
 
Graph 2. Graphical representation of non participant with various reasons. 
 
38.1% of non participant did not perceived need for Pap smear test because they feel that they 
are okay.29.6% of non participant lack time to come to screening clinic, 12.3% of o non 
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participant did not got permission from husband or in-laws to come to screening clinic, 8.6% 
of non participant were sick, 6.2% of non participant were ashamed to have gynaecological 
examination and 5.3% of women did not come to screening clinic because of fear of having 
gynaecological examination. 
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Chapter 5: Discussions 
 
5.1 Detection Rate of Abnormal Cervical Smear and Possible Causes 
Behind it: 
In our study we have found that the prevalence of different grades of abnormal smear (ASC, 
LSIL and HSIL) is 3.5% which is equivalent to 35 /1000 population. This finding of ours is 
some what higher than the prevalence of 2.5% abnormal smear detected on 2003, study 
conducted by IARC and BPKMCH in Bharatpur municipality. Probably this increment of 
prevalence in our study could be attributed to the sampling of the participants. In our study we 
have included age group 16-59 and in 2003 study age group are limited to 30-59 and 
Precancerous lesion, especially ASCUS and LSIL which occurs more among young sexually 
active women may have regressed back to normal by the age of 30 or above. The reason that 
we have included younger age group in this study is because in this project we also intended 
to find out the prevalence of HPV, which is more common in younger age groups. 
Out of 28 cases of ASC that was reported in our study 27(96.4%) of them are ASCUS and 
only 1(3.6%) is ASC-H. This is also accordance with other study finding of Pap smear 
reporting done on TBS 2001.(14) Our study has found higher proportion of women with HSIL 
(0.5 % of total smear )compared to LSIL which is only 0.2% of total smear. This is 
contradictory with most other study finding that proportion of women with LSIL is usually 
higher than HSIL. It could be due to the fact that there is less reproducibility for LSIL than for 
HSIL and the rate of LSIL is more variable than rate of HSIL. (43, 44) This can be also 
supported by the fact that 0.5% of HSIL in our study is exactly equal to median reporting rate 
of HSIL, found in study conducted in USA including 2000 laboratories for inter laboratory 
comparison program in cervicovagnal cytology.(45) In the same study 80% laboratories 
reported 0.64 to 4.23 with median ASCUS/SIL ratio of 2.0. Our finding of 3.85 ASCUS/SIL 
ratio is accordance with upper limit of this study. Rate of unsatisfactory smear in our study is 
0.8% and this is almost equal to the mean of 0.95% unsatisfactory smear found in this study. 
Thus the detection rate of abnormal smear in our study is more or less similar to the reporting 
done in different laboratories in USA using the Bethesda system. 
 unsatisfactory smear noted in our study are much lower compared to other study 
conducted in Norway and Iceland.(33,46) 19.4% of the women who had taken cervical 
smear were women age more than 45 in our study and mean age for menopausal 
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was 46.8 with standard deviation of 2 years. Inward shift of the transformation zone 
toward endo-cervical canal is common among postmenopausal women and makes 
collection of smear difficult. (47) Therefore unsatisfactory smear of 0.8% which we 
found in our study could be attributed to physiological changes of the women 
themselves rather than inappropriate collection of specimen by smear collector.  
The proportion of HSIL was found to be highest in age group 30-45 (3/5) compared to 1/5 in 
each age group 16-29 and 45-59. This is also accordance with another study conducted in 
Nepal, which showed that CIN2 and CIN 3 are common in age group31-40. (8)  
According to WHO, standard approach for management of HSIL or ASC-H is to refer 
for colposcopy and biopsy and confirmed cases of HSIL should be treated with 
Cryotherpay, LEEP or Cold knife conization. In our study, this was considered from 
the beginning and solidarity fund was allocated for the purpose. But to our surprise, 
4/5 HSIL positive in our study declined our offer to provide biopsy and treatment, 
despite several trial of persuasion. However no documentation was done, almost all 
of them said that they do not like to take out any tissue from there cervix and most of 
them also consulted previous women who have undergone treatment for 
precancerous lesion and they told them that the treatment makes them more sick 
with uncomfortable vaginal discharge. 
Partly this is true that one of the complication of Cryotherapy is prolonged and profuse watery 
discharge.(13) Probably this might have cause misconception of getting more sick after the 
treatment. Thus we lost the follow up of these women with HSIL, which is actually one 
of the most important components of screening programme. 
It has been already proven that persistence of high risk types of HPV is a prerequisite for 
development of CIN3 lesion and invasive cancer and one of the important determinants of 
acquisition of hrHPV is women with increase number of sexual partner.(23,24) Taking into 
consideration of the theory of the pathogenesis of cervical cancer which accounts infection of 
cervical epithelium with specific hrHPV, having cervical cancer as number one malignancy in 
Nepal, where most women practice monogamous relation contradicts the finding. 
In a setting where the role of Sexually Transmitted infection (STI) is not explained by the 
characteristics of the participant then it is mandatory to identify the role of their sexual partner 
from whom they may have acquired. Taking into consideration of this factor we have also 
surveyed the characteristics of their husband and found that significant proportion 26.7% of 
1033 women reported that their husband with other wife or cohabitant, 16.1% of 1033 
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reported husband with extramarital affair during their marriage and 22.7% of 1033 reported 
husband with extramarital affair before their marriage. 
Significant proportion of women reported having experienced signs and symptoms of STD, 
such as 50% 1033 women reported that they had abnormal vaginal discharge, 43.8% with 
genital sore or ulcer, 20% with genital wart and 16.2% were found to have inflammatory 
lesion on Pap smear finding. This concludes that STI among these women are common. 
Number of sexual partner of women is a sensitive issue especially in a strict society like 
Nepal. Therefore however we did our best to get reliable answer pertaining to lifetime number 
of sexual partner of women; we can not be very sure that if we have extracted the very 
reliable answer in this part.  
Nevertheless considering that almost all of these women have monogamous relationship; their 
husband’s extramarital affair must have played a role to acquire STI. This is further 
compounded by the fact that very few partners 42(4.1%) were found to use condom currently 
and that might have jeopardized the safer sexual behaviour and eventually lead to cervical 
cancer. The constraints on condom use of among men were also shown in another study 
conducted in Nepal. (43)  
Since HPV can affect any other part of genital area where condom does not cover, regular use 
of condom may not have a great effect for controlling HPV as other STD such as Chlamydia, 
HSV and Neisseria gonorrhoea. But controlling these other STI helps acquisition of the HPV. 
Thus change of behaviour for safe sex is utmost important factor to control cervical cancer. 
Societal behavioural pattern that are risk to develop cervical cancer such as low literacy rate 
among women, early marriage, early childbirth, high number of parity and women who are 
current smoker are found to be prevalent in our study.  These societal behavioural patterns of 
women and their husband’s role of having extramarital affair and unsafe sexual behaviour 
may have played role to have cervical cancer as number one malignancy in Nepal. 
 
5.2 Cervical Cancer Screening Coverage:  
As it has been mentioned above that one of the element of successful screening programme is 
high coverage (80%) and many developing countries has failed to accomplish this by over 
screening younger women than the women with risk group who have high chances to develop 
cervical cancer (women with age 35-45).Our finding also shows similar situation in the 
context of Nepal. 
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In our study we have found that 29% of 405 women who are age group 16-29 had Pap smear 
at least once. From this we can conclude that present opportunistic cervical cancer screening 
are directed toward screening women who have less risk compared to age group over 30. Our 
study also showed that 46.6% of 446 women with age group 30-44 and 42% of 193 women 
aged group 45-59 had previous pap at least once. This relatively high coverage of cervical 
cancer screening among  aged 30-44 and 45-59 could be due to the cervical screening 
provided to 5000 women aged 30-59 in 2003 while conducting Cryotherapy study between 
BPKMCH and IARC and the fact that women included in the study actually came to a 
screening, and are seriously biased  toward this type of behaviour.  
Many studies have shown that women with higher educational level are more likely to 
participate in screening clinic than with lower educational level. (36)Therefore another factor 
for relatively high coverage could be due to the fact that our study population were found to 
be more literate 55.2% compared to the nationwide adult female literacy rate of 28.7% 
according to demographic indicators of Nepal. (4) 
Thus in reality we can predict that the coverage must be way below than what we have found 
in our study. Therefore our finding is over estimation if it has to represent the cervical cancer 
screening coverage for total population.   
HSIL has highest probability of progression to invasive cancer. Based on our result with 
highest proportion of HSIL in age group 30-45, we can speculate that women within this age 
group should be the target group for cervical cancer screening in our setting. But meaningful 
conclusion can not be made at this point just based on 5 HSIL that we have found in our 
study. Thus more future researches should be carried out to find out the age specific 
prevalence of abnormal cervical smear to derive conclusion for specific target age group for 
cervical cancer screening. But to date, considering the limited resource in our country, few 
coverage of cervical cancer screening and yet to start organize cervical cancer screening the 
best and practical strategy to provide equitable cervical cancer screening service would be  to 
include women with age group between 35-45 once in her lifetime as WHO has 
recommended.  
Though its only one case, we have also found HSIL in age group younger than 30. Possible 
occurrence of HSIL in women younger than 30 years old were also shown in other previous 
studies.(46,49) This age group had also the highest proportion of ASCUS 12 (44.44%). A Meta 
analysis of 27,000 women showed that 0.3% of ASCUS progress to invasive cancer at 24 
months.(17) This concludes that this age group is also not risk free. Therefore in future when 
more resources is available and when screening coverage for highest risk group are increase 
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then we should also focus our attention to include younger women with age less than 30 
depending upon the age specific prevalence of abnormal cervical smear among them. 
 
5.3 Determining Barriers to Women’s Participation in Screening Clinic 
Health education is needed to ensure optimal programme coverage, which in turn will 
lead to increase program impact. Many barriers to cancer screening programme can 
be addressed through education of the community.    
Many studies have shown that in developing countries, barriers to cervical cancer 
screening uptake include absence of knowledge about the disease, lack of familiarity 
with the concept of preventive health care, geographic and economic inaccessibility 
of services, poor quality of services and lack of support from families and 
communities. (36) In our study, we have found 514(33.2%) of 1547 are non participant. 
In order to find out the barriers we have addressed few questionnaires to them for 
their reasons for non participation in this study. 
 We have found that majority of our non participant (38%) did not perceived need for 
Pap smear test because they feel that they are okay. This indicates that these 
women have not understood the rationale of the preventive approach of cervical 
cancer screening programme. This is also further supported by our finding that only 
26% think that cervical cancer is preventable when diagnosed at early course of the 
disease.  Utilization of preventive health services is not a norm in Nepal, particularly 
for elderly women. Therefore message about cervical cancer must include what 
cervical cancer is and how it can be prevented.   
Significant proportion (12.3%) of women also did not have permission from their 
husband and probably this could be due to lack of knowledge about cervical cancer 
among their husband. In our part of world where society is male dominated and 
female literacy is still very low, woman’s ability to make informed decision on about 
her health is not only influenced by her own beliefs and behavioural patterns, but also 
by her family and existing social networks. Thus for successful cervical cancer 
screening programme, information regarding cervical cancer should reach the 
husband and community at large.  
Some women (5.3%) have not participated in the screening clinic due to fear of being 
diagnosed as cancer. Probably this is due to perception of fatalistic attitude in relation 
to any cancer. For this change of attitude one must be knowledgeable about the 
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treatable nature of cervical cancer. In our study we have found only 24.7% have 
correctly responded when they were asked if cervical cancer is treatable when 
diagnosed at early course of the disease. Thus information on cervical cancer should 
contain the available treatment and where it can be available.   
Thus providing correct information on cervical cancer in the community and in health 
services is a key to raising awareness and reducing incidence and mortality. All 
categories of health care providers, in whatever setting they work, should provide 
correct and consistent information to women and men on cervical cancer, how it can 
be prevented, reasons for screening and the significance of it and management of 
any abnormality detected. 
Many studies have found that characteristics of underserved women in cervical 
cancer screening programme are women who are older than 45 years, poorer, less 
educated, unemployed or working in informal sector, living in non permanent 
dwellings without a partner, not familiar with other women who had undergone 
screening and were not regular clients of health care or family planning 
services.(35)We were not able to assess all these variables due to lack of time but our 
finding in relation to household settlement from slum versus non slum shows that 
there were more non participant from non slum are which are economically much 
better than slum area. This could be due to the fact that screening services were 
provided free of cost so that women from slum area did their best to take this 
opportunity whereas women from non slum area may have not felt this opportunity as 
important as women from slum area since they can afford health services when they 
need.  
Though we have not directly assessed the cost of cervical cancer screening as 
barrier to service utilization but from this we can derive a conclusion that if services 
are free of cost or at minimal price utilization of services by women from lower socio-
economic condition are favourable.  
In relation to age of the non participant our finding are similar to other study that most 
of the non participant are either too young or too old. (36)More than 90% of women 
belonging to age group 30-49 have participated in screening clinic. Therefore if we 
include our target screening age is 35-45 and frequency is once in a lifetime, based 
on our finding we can conclude that age will not be a problem.  
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5.4 Awareness and knowledge regarding cervical cancer 
Several studies have found that lack of awareness about cervical cancer and how to 
prevent it is an important obstacle to improving cervical cancer screening coverage. 
(37, 38, 39, 40) Thus ACCP recommends that cervical cancer screening programme in 
any country must increase awareness of cervical cancer and encourage women in 
their 30s and 40s to be screened in order to reduce incidence and mortality from 
cervical cancer. 
With this goal in our mind we have assessed the proportion of women who have 
heard of cervical cancer among our participant and found 40.9%of 1033 have heard 
of cervical cancer. Our study finding also shows that proportion of women who had 
previous Pap smear are more in women who have heard of cervical cancer than in 
those who have never heard. This shows that women who are aware of cervical 
cancer are more likely of having Pap smear.  
Some discrepancy has been found between proportion of women who are aware of 
cervical cancer and their actual knowledge about preventive and treatable nature of 
cervical cancer. This is shown by the fact that however 40.9% of 1033 women have 
heard of cervical cancer, only 26% of women were found to know correct information 
when asked if cervical cancer is preventable and only 24.7% were found to know if 
cervical cancer is treatable. 
Probably this could be attributed to the mode of information from which they have 
acquired this knowledge. Our finding has shown that among the 423 women who 
have heard of cervical cancer 47.8% have heard from health worker, 77.5% from 
relative, family and friends and 78.5% from mass media. Hence higher proportion of 
women has heard about cervical cancer through mass media and relative, family and 
friends compared to health worker. 
Considering the low literacy rate of women in Nepal, information that they have 
acquired through mass media  may not have understood fully or the information 
acquired through social networks such as family, friends and relatives may not be 
correct information due to lack of their own knowledge regarding the disease. 
Study conducted by ACCP in Cabanas project in El Salvador (36) showed that 
community health workers from ministry of health (MOH), who were trained in basic 
issues related to cervical cancer prevention, including risk factors and the priority age 
range for cervical cancer screening were effective means to promote cervical cancer 
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screening. Similarly, in Ghana community health nurses who have integrated cervical 
cancer screening outreach activities into existing child welfare clinic has resulted 
screening coverage increase from 4.62% to 6.56% in 5 month period. (36)  
 FCHV programme was initiated in Nepal in 1988/89 with the objective of promoting 
health and at present there are 47,873 FCHV actively working all over the country. 
The number of FCHV to population at district is 1:400 in Terai, where our study area 
is located, 1:250 in hills and 1:150 in mountains. (50)  
To date, the role of FCHV is mainly focussed on promotion of safe motherhood, child 
health, family planning and other community health services but not in promoting 
cervical cancer screening activities in public health approach. However it has been 
said that BPKMCH has trained some of the FCHV about cervical cancer screening 
awareness program but there role in population level were not yet found. 
With the access of these already existing FCHV in community it would be cost 
effective to train and utilize them for disseminating information as it has been done in 
above Cabanas project in El Salvador. Beside this all health worker in all level and all 
sector should be encouraged and mobilized to disseminate proper information to 
eliminate the above mentioned barriers. 
 
5.5 Strength of the study 
It is a population based study so that it gives better representation of total population 
compared to most of the hospital based study where there is a sampling bias, since 
most of the women who goes to hospital are either they are sick or they are the one 
who have better access of health facility due to various reason. 
This study is conducted in area where the precancerous lesion and cervical cancer 
treatment is possible. So that there will be good follow up of patient even after 
completion of this study. Regular follow up of women with abnormal cervical smear 
and proper referral of these women for needful management is crucial part of cervical 
cancer screening to have better impact on decrease incidence and mortality. 
This study is conducted in collaboration with IARC. As the Cancer research unit of 
WHO, IARC generates the scientific data useful for developing cancer control 
policies. Hence their expert suggestion and guidance helped this study to carry out 
as best as possible.  
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Solidarity fund is allocated for follow up of abnormal cervical smear and treatment of 
those women who cannot afford. This had given all women in this study an equal 
opportunity for treatment. 
To increase the validity of the Pap smear result in our study we have done our best 
to control the smear taker and smear reader bias.  
Cervical smears were taken by very well trained doctors and nurse and cervical 
smear was collected using both extended tip plastic Ayre’s Spatula and endocervical 
brush in order to assure collection of both ecto and endocervical specimen. This can 
be also proven by the fact that unsatisfactory smear noted in our study are much 
lower even than the study conducted in Norway and Iceland. (33,46) 19.4% of the 
women who had taken cervical smear were women age more than 45 in our study 
and mean age for menopausal was 46.8 with standard deviation of 2 years. Inward 
shift of the transformation zone toward endo-cervical canal is common among 
postmenopausal women.(47) Therefore unsatisfactory smear of 0.8% which we found 
in our study could be attributed to physiological changes of the women themselves 
rather than inappropriate collection of specimen by smear collector. 
All our Pap smear slides were read by single pathologist. Which helped to control the 
inter observer bias in reporting the result. Since this pathologist had also done her 
doctorate thesis in Pap smear reading and her work experience in BPKMCH helped 
to get the Pap smear result as reliable as possible. Pap smear reading was done on 
TBS and this nomenclature for reporting is also recommended by WHO. Detection 
rate of abnormal smear in our study was found to be more or less similar to detection 
rate in many laboratories in U.S.A.(45) where they also used the same reporting 
system. This further strengthens our reliability of the result.  
Data entries were done by two separate data entry personnel thus errors in recording 
data were controlled. Response rate for questionnaire were also found100% without 
missing value and though sampling process were not done by choosing women at 
random but at least cluster randomization was done to give the good representative 
sample for whole population.  
Validity of questionnaires used in our study is assured by pre-testing of questionnaire 
during pilot study. These questionnaires were also adapted from questionnaires that 
were used for assessment of reproductive morbidity in Nepal (41) and in Women’s Health 
survey in Norway. Sets of translated questionnaires from English to Nepali language were 
also concluded exact translation after checking by 3 Nepalese doctors. Thus by using 
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validated questionnaires and choosing interviewers with collage level of education secured a 
good quality of data collection.  
Data entries were done by two separate data entry personnel thus errors in recording 
data were controlled. Response rate for questionnaire were also found100% without 
missing value and though sampling process were not done by choosing women at 
random but at least cluster randomization was done to give the good representative 
sample for whole population. Thus we tried our best to maintain the validity and 
representability of the study.  
 
5.6 Weakness of the study 
Quality control of the Pap smear reading should be done by either reading all 
negative smears or at least 10% of the negative abnormal smear should be read by 
another pathologist and there should be reproducibility of the same result between 
these two readers. But in this study we failed to do so for various reasons as 
mentioned above in methodology portion. 
The usual recommendation for start of screening age is at the maximum prevalence 
of SIL lesions. But due to very few numbers in our study meaningful conclusion can 
not be made in this regard. 
Due to the misconception of the women in the community that treatment for pre-
cancer makes them more sick with more vaginal discharge made us loss of follow up 
for women with HSIL.Thus this limited us to provide effective treatment for these 
women who have high chances to have cervical cancer in future. 
Ideally women who shows signs of inflammation on per speculum examination 
should first be treated and recall later to have Pap smear. But such practice was not 
followed in our study because of high possibility of loss to follow up if specimen were 
not collected at that time. This may give false negative Pap smear result since there 
is a possibility that inflammatory cells may obscure abnormal cell beneath it. 
As a matter of fact 5000 women from Bharatpur municipality were offered cervical 
cancer screening services in 2003 and some women who were included in that study 
also attended this time in our study. Therefore by selecting these women we may 
had some response bias especially when it comes to awareness and knowledge 
regarding cervical cancer. 
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Women in our study area also represent women with better access of health service 
facilities, more urbanized and more literate than the other area of this district. 
Probably this kind of selection bias may result less representation of the total 
population. But considering the political unrest of our country at that time we are 
bound to choose a study area which is safer and practical enough to carry our daily 
activities.  
Due to limitation of time we have assessed awareness, knowledge and determinants 
of women’s barriers to undertake cervical cancer screening among these women by 
using structured questionnaire. Which may have resulted some response bias in 
information since most of the answers are already fixed and participants has no 
freedom to answer in their own way. Ideally these factor can be assessed more in 
depth by using open ended questionnaire or qualitative study such as focus group 
discussion, participatory observation etc. 
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Chapter 6:  Conclusion 
Rate of reporting of abnormal cervical smear in our study is more or less similar to 
the reporting done on many laboratory is USA.Though proportion of women with 
HSIL, which have higher chances to develop in to cervical cancer is low in our study 
compared to the finding in Norway and Finland, cervical cancer is number one 
malignancy in Nepal. Probably this can be attributed to the lack of cervical cancer 
screening services in Nepal. 
However almost all women in our study claimed to have monogamous relationship, 
Societal behavioural pattern that are risk to develop cervical cancer such as low literacy rate 
among women, early marriage, early childbirth, high number of parity and women who are 
current smoker are found to be prevalent in our study.  These societal behavioural patterns of 
women and their husband’s role of having extramarital affair and unsafe sexual behaviour 
may have played role to have cervical cancer as number one malignancy in Nepal. 
According to our study finding 29% of Pap smear coverage are among women who 
are younger than 30 years old and Pap smear screening coverage among 30-45 is 
just 45% despite completion of recent big cervical cancer screening study in the 
same area covering 5000 women of this age in year 2003-2004.  This concludes that 
cervical cancer screening coverage for women with highest risk is low.  
33% of the study population did not participated in the study and interestingly, these 
non participants are more from non slum area (area with higher socioeconomic 
status) compared to Slum area. This is probably due to free cervical cancer 
screening services that we offered in our study which made more participation rate 
from women with lower socioeconomic status. 
Major determinants of women’s barrier to utilize Pap smear clinic that we have 
detected in our study includes women’s lack of perception for need to utilize 
preventive health service like screening clinic (38.1%), Women’s lack of time 
(29.6%), lack of permission from husband to go to the screening clinic (12.3%). 
In our study we found that proportions of women who have ever heard of cervical 
cancer are 1.4 times more likely of having previous Pap smear compared to who 
have never heard. This shows that awareness of cervical cancer is important factor 
to have increase coverage rate for cervical cancer screening. 
Some discrepancy has been found between proportion of women who are aware of 
cervical cancer and their actual knowledge about preventive and treatable nature of 
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cervical cancer. Higher proportion of women in our study have heard of cervical 
cancer through mass media and social networks such as family, friends and  
relatives compared to health worker. Probably this can be attributed to either they 
have not understood the message completely from mass media or informant from 
social network may not have given correct information. 
In our study we have evidenced loss to follow up of women with HSIL. This is 
primarily due to misconception of previous women who had treatment for 
precancerous lesion that it cause more sick with uncomfortable vaginal discharge. 
This concludes that proper counselling of these women prior giving treatment is very 
necessary. Otherwise they may increase the false alarm in the community and 
hinders success of cervical cancer screening programme. 
Hence organized cervical cancer screening is necessary to increase coverage and 
campaign to increase awareness and knowledge regarding cervical cancer should 
start effectively according to the needs of community. 
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Chapter 7: Recommendations 
Experience in developed countries as mentioned above has shown that well planned 
organized screening programmes with high coverage can significantly reduce 
incidence of cervical cancer and mortality associated with it. Therefore since the 
infrastructure to run cervical cancer screening already exists in Bharatpur due to 
BPKMCH, organized screening service in this area is highly recommendable. 
Given the fact that we are at very early phase of providing cervical cancer screening 
services  we would like to recommend more realistic approach of  screening  women 
at their 30s and 40s (who are more likely to detect precancerous lesion) at least once 
in their lifetime than to screen women at any age.  
However this is more realistic approach, we would like to recommend future 
researcher to do more study to find out age specific incidence rate for precancerous 
lesion so that we can determine the actual target population for screening. 
Despite some awareness program initiated by BPKMCH our study found that only 
few are aware of cervical cancer and even among these women who are aware of 
cervical cancer lacks actual knowledge of cervical cancer. Therefore we recommend 
starting more awareness program suited to the needs of community. 
In a situation like our country where female literacy is low and worse in the age group 
30s and 40s, probably best way to disseminate information is face to face through 
trained personnel about health education. Thus we recommend training existing 
FCHV in community in regards to cervical cancer awareness and utilizing them for 
disseminating information. 
Based on our experience of women’s misconception about the precancerous 
treatment and  refusal to avail it  despite free of cost we would like to recommend  
that every women who need this sort of treatment should receive thorough 
counselling  with explaining advantage and possible disadvantage of the treatment 
before they receive their treatment.  
Increase awareness is not only matter of disseminating information but what is most 
important is disseminating correct information. Therefore we would like to 
recommend content of the message about cervical cancer should at least be what 
cervical cancer is, how it can be prevented, what treatments are available if 
diagnosed to have precancerous lesions or invasive cancer, advantages and 
disadvantage of these treatment strategy and where these services are provided. 
 53 
Based on our finding of women’s barrier for utilization of Pap smear screening clinic 
we would like to recommend: 
-Message that screening is a test that is applied to select asymptomatic individuals at 
risk of having or developing a disease should be clearly mentioned in a simple 
language. So that they may understand the role of preventive approach of cervical 
cancer screening and may realize that even women who are healthy is at risk. 
- Mobile cervical cancer screening camp are highly encouraged since this may 
provide opportunity to those women who does not get time to go to screening clinic. 
- Involvement of men and community at large for cervical cancer control is highly 
recommendable in order to have more women’s participation in Pap smear clinic. Probably 
this can be done by disseminating cervical cancer information by FCHV when 
meeting of mothers group are held once a month. Explaining sensitive issues like 
sexually transmitted disease to men by FCHV may not be culturally appropriate on 
our part of world. Therefore men’s participation in this aspect may play a better role 
to sensitize other men about these issue and allow there wife to have Pap smear to 
prevent having cervical cancer. 
Husband’s extramarital affair and lack of safer sexual behaviour noted in our study 
made us to recommend integrative approach of cervical cancer awareness with STD 
clinic in order to have better impact on long term cervical cancer control. STD clinic 
target younger age group of people than target group of cervical cancer screening 
women but educating these young groups of people about the consequence of 
unsafe sexual behaviour may prevent future occurrence of cervical cancer and also 
they may be crucial in persuading their family and community to utilize cervical 
cancer screening services in the community.     
Qualitative researches to identify the barriers to participate in cervical cancer 
screening are also highly recommendable to find out the community’s need and their 
perception about cervical cancer and cervical cancer screening services. Identifying 
these factors is essential to formulate specific information targeted to the need of 
community. 
Evaluation of the current screening services and identifying the problems are also 
highly recommendable. By doing this we can find out the problem area of services 
and changes can be made for better. 
After the international conference on population and development (ICPD) in Cairo in 
1994, Nepal has also developed National Reproductive Health policy and 
 54 
reproductive health of elderly including cancers was included as one of the essential 
components of national RH package.(51) But according to conference report which 
was held in Bangkok in 2005 and participated by 25 developing countries including 
Nepal showed that there is existence of gap in Nepal when it comes to formulate 
specific policy regarding cervical cancer prevention.(52)Thus this evidence based 
guidelines derived from our study would be helpful to implement national policies in 
this particular field. 
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Annex 2: Invitation Register 
Househol
d 
Subject 
identificati
on number 
(study =3 
digits,  
subject=4 
digits) 
Full 
name 
Age
1 
Marit
al 
Statu
s2 
Date of 
appointm
ent 
DD/MM/YY 
Date of  
screenin
g 
DD/MM/
YY 
Date of  
re-
invitatio
n 
DD/MM/
YY 
Reason for  
non-
participati
on3 
 
|__|__|__|
__| 
|1||4||2|-
|__||__||__||
__| 
 
|__||_
_| 
      
         
         
         
         
         
         
         
         
         
         
         
         
         
 
If the exact age is unknown, give estimation, 2Codes for marital status: 1) single; 2) 
married; 3) separated or divorced; 4) widow, 
 3Codes for non-participation: 1) too sick; 2) lack of time 3) no need to have an 
examination or blood sample collection; 
 4) Fear of gynecological examination or blood sample collection; 5) lack of permission 
from husband/parents; 6) other. 
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Annex 3: Invitation card (to be completed and delivered at time of recruitment) 
 
II nvii tt att ii on  Carr d  
Cervical cancer screening 
BP Koirala Memorial Cancer Hospital/  
World Health Organisation 
 
Identification label 
 
 
 
 
 
 
 
Subject identification number : |1||4||2|-|__||__||__||__| 
 
Household : |__||__||__||__|  
 
 
Full name : …..………..……………………………..…… 
  
Date of visit(DD/MM/YY) : |__|__|/|__||__|/|__||__|    
 
 
Address of the clinic : 
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Annex 4 Human Papillomavirus  Prevalence  Surveys in Bharatpur, Nepal 
 
INFORMED CONSENT FORM 
Cervical cancer is the most common cancer in Nepalese women. It develops following the 
infection of the cervix by a virus, the human papillomavirus. If the lesion in the cervix is 
detected early, cancer can be prevented, or at least treated effectively. You are invited to 
participate in a study aimed at improving the prevention of cervical cancer. This study is 
being performed in collaboration with the International Agency for Research on Cancer, 
Lyon, France. 
 
I hereby agree to participate in the Human papillomavirus (HPV) Prevalence Survey in 
Bharatpur, Nepal. I understand that the goal of the project is to improve the understanding 
and prevention of cervical cancer.  
 
If I participate, I will be asked questions about my background, education, pregnancies, 
family planning, health, smoking and lifestyle. Some of the questions will be personal. I can 
refuse to answer any question that bothers me.  
 
I understand that a trained midwife or physician will perform an exam of my vagina and 
cervix, and that, during the examination; a specimen of cells from my cervix will be taken 
using a specially designed plastic brush. This cervical specimen will be used to test for 
cervical abnormalities as well as for the presence of human papillomavirus and other 
infectious agents. In addition, the midwife or physician will draw a small amount of blood 
which will be used to test for the presence of antibodies to human papillomavirus and other 
infectious agents. Some of the tests on the cervical specimens and blood will be research 
tests. I understand that standard medical procedures will be used for all the exams and the 
tests used in this study.  
 
If any disease is found as a result of the examinations, I understand that I will be notified and 
referred for proper additional examinations and treatment if needed.  
 
Minor bleeding may result from the cervical examination and very rarely infection may result. 
There may be some minor discomfort or soreness from the blood drawing and rarely a bruise 
may develop. Although the risk from these procedures is minimal, in the unlikely event that 
there are adverse reactions, I understand that I will be treated.  
 
All medical and personal information obtained in this study which would permit identification 
of any individual will be held in strict confidence and will be used only for research purposes. 
My name and other identifying information will not appear in any report of the study.  
 
I understood information about the objectives of the study, benefits and risks associated with 
participation, and assurance of the confidentiality of the information when delivered orally to 
the whole group. 
 
My participation is voluntary and I may refuse to take part in any of the study procedures at 
any time without penalty or loss of any benefits. For further information about this study I can 
contact Dr.Ang Tshering Sherpa at Himal Path Bharatpur, Tel no. 056-522292. 
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Please indicate whether you would like to participate in each component of the study by 
checking the line next to each item below: 
 
_____ cervical cell sample collection  
_____ blood sample collection 
_____ risk factor questionnaire 
 
I show my willingness to undergo the above procedures and to answer the question by 
putting my signature or thumb prints on this form 
 
______________________________  ______________________________ 
Signature                  Date 
 
Study ID number:             
     
I testify that I have, to the best of my ability read and explained the information concerning 
this research study to the participant whose identification number appears above. 
 
Interviewers 
 
______________________________  ______________________________ 
Signature                  Date 
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Annex 5 Individual Questionnaire 
 
IMPORTANT notes for filling the questionnaire 
EVERY question should be replied to. Use the following codes : 
9 (1 box) or 99 (2 boxes) for « don’t know » or « do not want to reply»  
8 (1 box) or 88 (2 boxes) for « does not apply » 
Under NO circumstances should any box be left empty 
(e.g. : to reply 2, note |_0_||_2_|) 
 
IMPORTANT : Questionnaire should be verified immediately after completion 
 
 
Identification label 
 
 
 
 
1.  Household |__||__||__||__| 2. Subject identification number : |1||4||2|-
|__||__||__||__| 
3. Full name : ……………………………..…………………..……………………………..…… 
4. Age : |__||__|           (IMPORTANT : If exact age is unknown, give an estimation )  
5. Date of birth (DD/MM/YY)                                                       |__||__|/|__||__|/|__||__| 
6. Additional contact information (telephone , address, …) 
……………………………………………………..……………………………….……………………
…………..………………………………..……………………………….………………………. 
 
7. Date (DD/MM/YY)                                                                             |__||__|/|__||__|/|__||__| 
8. Name of interviewer : ………………………………………………            code: |__||__| 
 
Demographic data 
9. What is your religion? (1: Hindu, 2: Buddhist, 3: Christian, 4: Muslim)            
 |__| 
10. What is your marital status? (1: single, 2: married, 3: separated or divorced, 4: 
widow) |__| 
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11. How old were you when you first married?           |__||__| 
 
Subject identification number:  |1||4||2|-|__||__||__||__|      
 
12. Have you ever been to school ? (1: yes, 2: no)       
 |__| 
13. If yes, what is your highest level of schooling?   |__|
                 
(1: primary, 2: secondary, 3: completed school leaving certificate, 4: higher 
degree)  
14. What is your current occupation?        |__| 
1: unemployed 
2: house-wife  
3: manual work (titling field for other, cleaning, cooking, labor etc.) 
4: merchant/shop-keeper (fruit and vegetables vendor, tea shop etc.) 
5: clerical work (teacher, nurse, secretary, clerks) 
6: professional (doctor, lawyer, engineer, project officer) 
15. What is your husband’s current occupation?       |__| 
1: unemployed 
2: farmer 
3: manual work (titling field for other, cleaning, cooking, labour etc.) 
4: merchant/shop-keeper (fruit and vegetables vendor, tea shop etc.) 
5: clerical work (teacher, nurse, secretary, clerks) 
6: professional (doctor, lawyer, engineer, project officer) 
7: migrant worker 
8: Driver 
 
Medical history  
16. Are you currently pregnant? (1: yes, 2: no)      |__| 
If yes, the women should complete the questionnaire and blood sample,  
but should not be offered a gynaecological examination 
17. Are you currently menstruating ? (1: yes, 2: no)     
 |__| 
If yes, the women should complete the questionnaire and blood sample, and  
be re-invited  7-10 days from the start of her period for gynecological examination 
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18. Have you ever had previous screening for cervical cancer (Pap test)?  
 |__|  
 (1: yes, 2: no) 
19. As far as you know, have you ever had tuberculosis? (1: yes, 2: no)   |__| 
20. As far as you know, have you ever had malaria? (1: yes, 2: no)   
 |__| 
21. Have you ever had any of the following signs or symptoms? (Explain that consistency 
abnormal vaginal discharge can be watery, whitish, yellowish, purulent, mucoid, foul smelling 
and amount can vary from scanty to excessive)   
Abnormal vaginal discharge (1: yes, 2: no)     
 |__| 
Genital ulcer/genital sores (1: yes, 2: no)      |__| 
Genital warts (1: yes, 2: no)       |__| 
  
Subject identification number:  |1||4||2|-|__||__||__||__|      
 
Smoking history  
22. Have you ever regularly smoked?                   |__| 
(1: yes, currently, 2: yes, but only in the past, 3: no)  
23. At what age did you start smoking?                               |__||__| 
24. At what age did you stop smoking?                                                                      |__||__| 
25. How many cigarettes per day?                                                |__||__| 
26. Have you ever regularly chewed tobacco?                   |__| 
(1: yes, currently, 2: yes, but only in the past, 3: no)  
 
Reproductive history 
27. At what age did you start menstruating?                       
|__||__| 
28. Are you menopausal? (Over 40 and 12 months without periods)?   |__| 
  (1: yes, 2: no) 
29. If menopausal, at what age did you have your last period?                 |__||__| 
30. Have you ever been pregnant? (1: yes, 2: no)      
 |__| 
31. How many full-term pregnancies have you had?            |__||__| 
32. How old were you at your first birth?             |__||__| 
33. How old were you at your last birth?             |__||__| 
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34. Have you ever had a spontaneous abortion? (1: yes, 2: no)        |__|
  
35. If yes, how many?                
|__||__| 
36. Have you ever had a voluntary abortion? (1: yes, 2: no)      
  |__| 
37. If yes, how many?                      
|__||__| 
 
 
 
 
 
 
 
 
 
 
 
Subject identification number :  |1||4||2|-|__||__||__||__|      
 
Contraceptive history 
38. Have you or your partner ever used the following contraceptives?  
Pill (1: yes, currently, 2: yes, but only in the past, 3: no)   
  |__| 
Injectable contraceptives (1: yes, currently, 2: yes, but only in the past, 3: no)
  |__| 
Intra-uterine device (1: yes, currently, 2: yes, but only in the past, 3: no) 
  |__| 
Condom (1: yes, currently, 2: yes, but only in the past, 3: no)   
 |__| 
Tubal ligation (1: yes, currently, 2: yes, but only in the past, 3: no)  
 |__| 
Other, please specify…………………………………|______________________________| 
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For users of pill or injectable contraceptives  
39. At what age did you start using this type of contraception?          |__||__| 
40. At what age did you stop using this type of contraception?                    |__||__| 
      (Current age for current use) 
 
-Now I will ask you some very personal questions. If you accept to answer please be 
sure that this information will be kept absolutely confidential. 
Sexual history 
41. At what age did you first have sexual intercourse?                   |__||__| 
42. Do you have any children who have a father other than your husband?          |__| 
 (1: yes, 2: no) 
43. In your entire life, how many men have you had sexual intercourse with?       |__||__| 
44. Does your husband have any other wife/cohabitant than yourself? (1: yes, 2: no)     |__| 
45. Does your husband have any children by a woman other than yourself?      |__| 
 (1: yes, 2: no)    
46. To your knowledge, has your partner/husband had had sexual intercourse with other   
women: Before becoming your partner/husband? (1: yes, 2: no)    |__| 
Whilst your partner/husband? (1: yes, 2: no)      |__| 
47.  Where does your husband currently live?      |__| 
  (1: with you, 2: elsewhere) 
48.  How often is your husband away from home?       
 |__| 
        (1: <1 night/month, 2: 1-3 nights/month, 3: 4-7 nights/month, 4: >7 nights/month) 
 
 
 
Subject identification number :  |1||4||2|-|__||__||__||__|      
 
Clinical examination 
49. Did the woman have blood sample taken? (1: yes, 2: no)       
  |__| 
If no, please specify why not ____________ 
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50. Did the woman have sample taken for HPV? (1: yes, 2: no)     
 |__| 
If no, please specify why not ____________         
 
51. Did the women have sample taken for Pap smear? (1: yes, 2: no)    
 |__| 
If no, please specify why not ____________        
 
 
 
 
52. Pap smear test result          
 |__| 
1: normal/ normal but inflammatory           
2: ASCUS  
3: ASC-H 
4: AGUS/AGC 
5: LSIL  
6: HSIL 
7: invasive cancer  
 
53. Have you ever heard about cervical cancer prior, to our staffs visit to your house for this 
study purpose? 
(1: yes, 2: no)                                             |__| 
If participant responded “yes” go to question number 54, 55, 56. Otherwise skip these 
questions and go to question number 55. 
54. Did you hear from health worker? 
(1: yes, 2: no)                                             |__| 
54. Did you hear from mass media? 
(1: yes, 2: no)                                             |__| 
54. Did you hear from family/friends/relatives? 
(1: yes, 2: no)                                             |__| 
55. In your opinion do you think women can be prevented of getting cervical cancer? 
(1: yes, 2: no, 3: I don’t know)                                             |__| 
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56. In your opinion do you think cervical cancer can be treated if it is diagnosed at early 
course of disease? 
(1: yes, 2: no, 3: I don’t know)                                             |__| 
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Annexs 6: Ethical Clearance from Nepal Health Research Council. 
 
 
 
